Your browser doesn't support javascript.
loading
Early Decision Making in a Randomized Phase II Trial of Atezolizumab in Biliary Tract Cancer Using a Tumor Growth Inhibition-Survival Modeling Framework.
Shemesh, Colby S; Chan, Phyllis; Marchand, Mathilde; Gonçalves, Antonio; Vadhavkar, Shweta; Wu, Benjamin; Li, Chunze; Jin, Jin Y; Hack, Stephen P; Bruno, Rene.
Afiliação
  • Shemesh CS; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
  • Chan P; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
  • Marchand M; Certara Strategic Consulting, Paris, France.
  • Gonçalves A; Certara Strategic Consulting, Paris, France.
  • Vadhavkar S; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
  • Wu B; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
  • Li C; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
  • Jin JY; Clinical Pharmacology, Genentech Inc., South San Francisco, California, USA.
  • Hack SP; Product Development Oncology, Genentech Inc., South San Francisco, California, USA.
  • Bruno R; Clinical Pharmacology, Genentech-Roche, Marseille, France.
Clin Pharmacol Ther ; 114(3): 644-651, 2023 09.
Article em En | MEDLINE | ID: mdl-37212707

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Sistema Biliar / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article